Aurexis
Aurexis Uses, Dosage, Side Effects, Food Interaction and all others data.
Aurexis is under investigation in clinical trial NCT00198289 (Aurexis® in Cystic Fibrosis Subjects Chronically Colonized With Staphylococcus Aureus in Their Lungs).
| Trade Name | Aurexis |
| Generic | Tefibazumab |
| Tefibazumab Other Names | Tefibazumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Aurexis
